Kimia Biosciences shareholding pattern

KIMIABL

36.89

1.37 (3.86%)
Last updated on 14 May, 2026 | 15:26 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Kimia Biosciences Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

74.94%

Mutual Fund

1.24%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

23.82%

Others

0%

Total Promoters
MAR '18
50.48%
JUN '18
50.48%
SEP '18
50.48%
DEC '18
74.94%

Summary

Kimia Biosciences share holding pattern reports the following shareholding: Kimia Biosciences Total Promoters is at 74.94%, Mutual Fund at 0.38%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 24.68%. This breakdown provides a quick snapshot of ownership distribution for Kimia Biosciences share holding pattern in 2026-27.

Kimia Biosciences FAQs

As of 05-2026, the promoter shareholding in Kimia Biosciences stands at 74.94% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Kimia Biosciences is 0% and 0% respectively.

The retail shareholding of the Kimia Biosciences is 24.68%.

Changes in shareholding patterns of Kimia Biosciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Kimia Biosciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost